Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,278 results for "Medical Malpractice Law & Strategy"...

Verdicts
July 30, 2013
In-depth analysis of recent important cases.
Med Mal News
July 30, 2013
Analysis of key rulings.
Drug & Device News
July 30, 2013
A look at several rulings.
The Media
July 30, 2013
How often do we hear that "everybody sues" in the United States, and that there are "jackpot juries" handing out huge sums of money to undeserving plaintiffs? Is the media to blame for these skewed beliefs or is the media accurate in its portrayal of the tort system, especially the medical malpractice system?
Suits Against Generic Pharm Manufacturers
July 29, 2013
What a recent Supreme Court decision does is to effectively immunize pharmaceutical generics manufacturers from state tort liability when they use FDA-approved labels for their products deemed equivalent to brand-name FDA-approved drugs.
Verdicts
June 21, 2013
An in-depth look at recent important rulings.
Med Mal News
June 21, 2013
A look at several recent news items.
Drug & Device News
June 21, 2013
A look at several key cases.
Dangerous Patients and the Tarasoff Doctrine
June 21, 2013
Psychiatrists and other mental health practitioners must know the reporting laws in their own jurisdictions, and take the required steps under those laws, if they want to avoid liability when a patient follows through on a threat to harm someone else.
Medical Malpractice Claim or EMTALA Violation?
June 21, 2013
What are the causes of action for an EMTALA claim? What constitutes an "adequate" screening, and how can a plaintiff show that the screening he or she received fell short?

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›
  • Meet the Lawyer Working on Inclusion Rider Language
    At the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers &amp; Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.
    Read More ›